Logo image of GRA.CA

NANOXPLORE INC (GRA.CA) Stock Fundamental Analysis

TSX:GRA - Toronto Stock Exchange - CA63010G1000 - Common Stock - Currency: CAD

2.32  -0.08 (-3.33%)

Fundamental Rating

3

Taking everything into account, GRA scores 3 out of 10 in our fundamental rating. GRA was compared to 29 industry peers in the Chemicals industry. The financial health of GRA is average, but there are quite some concerns on its profitability. GRA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GRA has reported negative net income.
GRA had a positive operating cash flow in the past year.
GRA had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GRA reported negative operating cash flow in multiple years.
GRA.CA Yearly Net Income VS EBIT VS OCF VS FCFGRA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

GRA's Return On Assets of -6.48% is in line compared to the rest of the industry. GRA outperforms 58.62% of its industry peers.
GRA's Return On Equity of -9.69% is fine compared to the rest of the industry. GRA outperforms 62.07% of its industry peers.
Industry RankSector Rank
ROA -6.48%
ROE -9.69%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRA.CA Yearly ROA, ROE, ROICGRA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

With a Gross Margin value of 18.57%, GRA perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
GRA's Gross Margin has improved in the last couple of years.
GRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
GRA.CA Yearly Profit, Operating, Gross MarginsGRA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

5

2. Health

2.1 Basic Checks

GRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GRA has been increased compared to 5 years ago.
GRA.CA Yearly Shares OutstandingGRA.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M
GRA.CA Yearly Total Debt VS Total AssetsGRA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M

2.2 Solvency

GRA has an Altman-Z score of 4.98. This indicates that GRA is financially healthy and has little risk of bankruptcy at the moment.
GRA has a better Altman-Z score (4.98) than 82.76% of its industry peers.
GRA has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.14, GRA belongs to the best of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 4.98
ROIC/WACCN/A
WACC7.82%
GRA.CA Yearly LT Debt VS Equity VS FCFGRA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

GRA has a Current Ratio of 1.99. This is a normal value and indicates that GRA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.99, GRA is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
A Quick Ratio of 1.44 indicates that GRA should not have too much problems paying its short term obligations.
The Quick ratio of GRA (1.44) is better than 65.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.44
GRA.CA Yearly Current Assets VS Current LiabilitesGRA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

GRA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The Revenue has grown by 9.12% in the past year. This is quite good.
The Revenue has been growing by 13.33% on average over the past years. This is quite good.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%

3.2 Future

The Earnings Per Share is expected to grow by 29.59% on average over the next years. This is a very strong growth
Based on estimates for the next years, GRA will show a quite strong growth in Revenue. The Revenue will grow by 17.87% on average per year.
EPS Next Y15.83%
EPS Next 2Y36.23%
EPS Next 3Y45.72%
EPS Next 5Y29.59%
Revenue Next Year9.38%
Revenue Next 2Y16.93%
Revenue Next 3Y25.67%
Revenue Next 5Y17.87%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GRA.CA Yearly Revenue VS EstimatesGRA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
GRA.CA Yearly EPS VS EstimatesGRA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.05 -0.05 -0.1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GRA. In the last year negative earnings were reported.
Also next year GRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRA.CA Price Earnings VS Forward Price EarningsGRA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as GRA.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 99.19
GRA.CA Per share dataGRA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

GRA's earnings are expected to grow with 45.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.23%
EPS Next 3Y45.72%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GRA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANOXPLORE INC

TSX:GRA (7/14/2025, 7:00:00 PM)

2.32

-0.08 (-3.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)09-16 2025-09-16/amc
Inst Owners12.56%
Inst Owner ChangeN/A
Ins Owners7.38%
Ins Owner ChangeN/A
Market Cap395.82M
Analysts76
Price Target3.83 (65.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.99%
Min EPS beat(2)-53.98%
Max EPS beat(2)33.99%
EPS beat(4)2
Avg EPS beat(4)-8.63%
Min EPS beat(4)-53.98%
Max EPS beat(4)33.99%
EPS beat(8)4
Avg EPS beat(8)-15.47%
EPS beat(12)6
Avg EPS beat(12)-31.39%
EPS beat(16)7
Avg EPS beat(16)-61.64%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-14.65%
Max Revenue beat(2)-5.03%
Revenue beat(4)0
Avg Revenue beat(4)-6.39%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)-1.56%
Revenue beat(8)1
Avg Revenue beat(8)-5.88%
Revenue beat(12)4
Avg Revenue beat(12)-2.77%
Revenue beat(16)5
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)-12.6%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-4.12%
Revenue NQ rev (3m)-17.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.92
P/FCF N/A
P/OCF 90.39
P/B 3.92
P/tB 4.55
EV/EBITDA 99.19
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.03
OCFY1.11%
SpS0.79
BVpS0.59
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.48%
ROE -9.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.57%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y46.47%
GM growth 5Y4.81%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 3.63
Cap/Depr 108.56%
Cap/Sales 8.99%
Interest Coverage N/A
Cash Conversion 109.67%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.44
Altman-Z 4.98
F-Score5
WACC7.82%
ROIC/WACCN/A
Cap/Depr(3y)78.57%
Cap/Depr(5y)156.07%
Cap/Sales(3y)6.19%
Cap/Sales(5y)12.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y15.83%
EPS Next 2Y36.23%
EPS Next 3Y45.72%
EPS Next 5Y29.59%
Revenue 1Y (TTM)9.12%
Revenue growth 3Y24.8%
Revenue growth 5Y13.33%
Sales Q2Q%-10.1%
Revenue Next Year9.38%
Revenue Next 2Y16.93%
Revenue Next 3Y25.67%
Revenue Next 5Y17.87%
EBIT growth 1Y44.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year143.09%
EBIT Next 3Y68.1%
EBIT Next 5Y71.57%
FCF growth 1Y23.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y248.81%
OCF growth 3YN/A
OCF growth 5YN/A